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SUMMARY
BACKGROUND AND OBJECTIVES: To review 
neuralgia inducing cavitational osteonecrosis (NICO), 
its differential diagnosis with regard to major facial 
pains as well as its management. 
CONTENTS: NICO is a disease with numerous 
causes, such as trauma, infections, use of local anes-
thetics with vasoconstrictors which decrease blood 
flow inside the bone, direct or indirect applica-
tion of heavy metals and steroids after oral surger-
ies, use of nicotine and coagulation problems. The 
diagnosis is based on the clinical history associated to pain 
quality, duration and in general ineffective thera-
peutic response to different neuromodulators. 
Complementary exams are standard periapical X-rays 
of the area to be investigated, panoramic X-rays and 
CT, which may show or not unilocular radiolucent foci. 
Scintigraphy normally shows an area of increased up-
take. Treatment may be clinical with anticoagulants, 
anabolic steroids or local antibiotic injection; or sur-
gical promoting local bleeding by osteotomy or ostec-
tomy, depending on NICO level and extension.
CONCLUSION: The search for new drugs less detri-
mental for bone tissues and more information to den-
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tists about NICO may help decreasing its incidence 
by establishing an earlier diagnosis, thus making 
different management techniques more effective.
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RESUMO
JUSTIFICATIVA E OBJETIVOS: Realizar uma 
revisão sobre a neuralgia induzida por cavitação 
osteonecrótica (NICO) seu diagnóstico diferencial em 
relação às principais dores bucofaciais, bem como o 
seu tratamento.
CONTEÚDO: A neuralgia pela NICO é uma doença 
que tem inúmeras causas, como trauma, infecções, o 
emprego de anestésicos locais com vasoconstritores 
que diminuem o fluxo sanguíneo no interior do osso, 
a aplicação direta e/ou indireta de metais pesados, de 
corticosteroides, pós-cirurgias bucais, o uso de nicotina 
e problemas de coagulação. O diagnóstico baseia-se na 
história clínica associada à qualidade da dor, duração, 
resposta terapêutica normalmente ineficaz ao uso de dif-
erentes neuromoduladores. Emprega-se, como exames 
complementares, radiografia periapical padrão da área 
a ser investigada, radiografia panorâmica, tomogra-
fia computadorizada que podem demonstrar, ou não, 
focos radiolúcidos uniloculares. O exame cintilográf-
ico apresenta normalmente área de hipercaptação. O 
tratamento pode ser clínico conservador utilizando 
anticoagulantes, esteroides anabolizantes, injeções de 
antibióticos no local, ou cirúrgico, promovendo o san-
gramento local por osteotomia ou ostectomia, depend-
endo do grau e extensão da NICO. 
CONCLUSÃO: A pesquisa de novos medicamentos, 
menos prejudiciais aos tecidos ósseos, e maior in-
formação aos cirurgiões-dentista sobre a NICO po-
dem ajudar a diminuir sua incidência, estabelecendo 
o diagnóstico mais precocemente e consequente-
Neuralgia Inducing cavotational.indd   156 6/21/12   2:32 PM
Neuralgia inducing cavitational osteonecrosis Rev Dor. São Paulo, 2012 jan-mar;13(1):000-0
157Sociedade Brasileira para o Estudo da Dorc
mente tornando mais eficaz as diferentes formas de 
tratamento.
Descritores: Dor neuropática, Dor orofacial, Neural-
gia induzida por cavitação osteonecrótica, Tratamento 
cirúrgico, Tratamento clínico.
INTRODUCTION
Neuralgia inducing cavitational osteonecrosis (NICO) 
is a disease characterized by cavitary lesions in the 
mandible and/or jawbone, very often not radiologically 
detectable1,2. It may be caused by trauma, such as dental 
extraction, endodontics and secondary alveolar hemor-
rhage, or even by an infectious process3-5.
NICO has been pointed as frequent cause of face 
neuralgias involving the trigeminal territory. It is a 
severe, piercing pain like an electric shock, of short 
duration which does not wake up the patient and 
some times is continuous3,4,6-9. It affects more fe-
males than males and may partially or totally dis-
appear after anesthetic block of the painful area. At 
neurological evaluation, cranial pairs are normal10. 
Such bone radiolucent areas may be detected or not1,2 
through periapical or panoramic X-rays, CTs and 
MRI1, but the golden standard is bone scintigraphy11.
Due to lack of knowledge of health professionals it 
is called atypical facial pain. In fact, it is an ischemic 
necrosis of the alveolar bone. Current studies describe 
ischemic alveolar bone marrow coagulation disorders 
as the cause for NICO, which may also be the result 
of thrombosis with or without hypofibrinolysis, which 
would obstruct vascular spaces impairing blood flow 
in the region12-14. So, it could be treated with anti-
coagulants or anabolic steroids15-18.
Other therapeutic options would be regional osteotomy 
and curettage of the painful area, or osteotomy associated 
to local application of absorbable gelatine sponge asso-
ciated to tetracycline, with tetracycline and cephalexin, 
or clindamicine with gentamicine1-4,9. Treatment is de-
cided in a case-by-case basis, depends on professional’s 
experience, on previous treatments, on the extension 
of the involved area and on patient’s general status. If 
the choice is surgery, removed bone should be sent for 
pathologic exam. 
For such, and aiming at finding adequate and relevant 
studies, the following terms were combined: asep-
tic necrosis of bone, ischemic necrosis, avascular 
osteonecrosis, osteonecrosis of jaw, neuralgia indu-
cing cavitional, osteonecrosis, jawbone cavities. 
The following databases were queried: BBO,Cochrane, 
LILACS and Medline in the period from 1970 to 
2011, supplemented by manual query of journals and 
chapters of books. This query was limited to studies in 
humans written in Portuguese and English.
GENERAL NICO CHARACTERISTICS
NICO is a sequela of the action of several local fac-
tors which impair vascularization of the affected bone 
region1. It was defined as a neurogenic pain syndrome 
caused by decreased bone vascularization with conse-
quent tissue necrosis and formation of bone cavities 
difficult to see by imaging exams1,2. Together with 
bone marrow edema and regional ischemic osteopor-
osis, ischemic necrosis may lead to the development 
of NICO. This is one of the commonest human bone 
diseases, but only recently it has been evaluated as a 
head and neck disease2.
Bone tissue necrosis and formation of cavities were 
justified 31 years ago by the continuity of chronic in-
fectious processes triggered after tooth extraction in 
alveolar processes both of jawbone and mandible3,4. 
Professionals hardly associated facial pains to neural-
gias or to bone origin, classifying pains with no den-
tal origin as psychogenic. Studies in this area have 
advanced and some authors3 have found association 
between patients suffering of facial pain and bone le-
sions of infectious origin, which may be caused by 
nonspecific aerobic or specific anaerobic bacteria.
The first series of studies reporting asymptomatic 
cavitary bone lesions difficult to diagnose by con-
ventional methods was published in 19765. In 1926, 
the neurosurgeon Wilfred Harris presented an etio-
logic theory where a chronic, low-intensity maxil-
lomandibular bone infection surrounding some tri-
geminal branches could cause constant orofacial 
pain. This infection would cause neural degeneration 
or demyelination generating an anomalous nervous 
impulse pattern and, as a consequence, an abnormal 
pain1. Over the years, with the advance of imaging 
diagnosis processes and the study and detection of 
genetic changes, one may also include as a cause of 
NICO the decreased bone marrow blood flow caus-
ing bone cavities. All of this was also associated to 
genetic mutations which would predispose patients 
to thrombophilia and hypofibrinolysis13,14.
Initially, NICO etiopathogenesis was considered 
infectious with lesions caused by microorganisms 
in alveolar bone lesions region and consequent 
osteomyelitis and bone necrosis5. With the advance of 
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diagnostic studies and disease identification, some au-
thors1,9 have suggested two major theories for NICO 
etiopathogenesis: one is infectious, considering bac-
teria as major disease-causing agents; the other is is-
chemic which has as its major cause bone tissue in-
farction due to lack of blood irrigation.
DEVELOPMENT MECHANISM AND ETIOLOGY
NICO development mechanism is still being studied1, 
however NICO triggering factor would be a local 
trauma associated to pathological process triggering 
factors being five of them already described: the first 
suggests that patients may have some local or sys-
temic immunodeficiency which impairs local infec-
tion elimination. The second would be the presence 
of specific pathogenic bacteria stimulating, during the 
inflammatory process, tissue necrosis, thus impairing 
vascularization leading to infarction and necrosis. 
The third mechanism suggests that the lack of tissue 
vascularization leads to hypoxia or bone marrow in-
farction generating less resistance to pathogens and 
making odontogenic infections easier. The fourth hy-
pothesis supposes a lack of neutrophils and / or macro-
phages, which would lead to decreased chemotaxis 
and phagocytosis, promoting infections installation 
and propagation. The fifth and last mechanism would 
be the lack or decrease of bone growth factors manda-
tory for new bone formation, as well as a change in 
tissue pH decreasing osteoinducing potential1.
In addition to etiological factors, NICO has worsening 
and hereditary factors associated to the disease. Re-
searchers13,15,16 have concluded that patients with such 
neuralgia have differences in coagulation factors which 
are common as hereditary forms of thrombophilia 
and hypofibrinolisis, also related to risk factos such 
as femoral head osteonecrosis. Seventy-one percent 
of NICO cases are caused by alcohol abuse, trauma, 
prednisone, estrogen, pregnancy, sickle cell anemia, 
lupus erythematosus and use of chemotherapy for ma-
lignant neoplasias. Smoking and atherosclerosis are 
less commonly associated19.
Seldom associated to this disease are osteomielytis 
and  inanition16. Bisphosphonates are also to be added 
to these risk factors20. These drugs act by decreasing 
bone reabsorption, especially by inhibiting recruit-
ment and inducing osteoclasts apoptosis. In addition 
to decreased osteoclast activity there is inhibition of 
growth factors and other bone matrix factors release. 
Its use has been associated to NICO, especially in pa-
tients submitted to tooth extractions20,21. The best way 
to prevent bone necrosis problems in dental procedures 
is an adequate oral exam and the treatment of all den-
tal needs of the patient, especially removing infection 
foci, before starting bisphosphonates therapy22.
The risk for osteonecrosis with this drug increases 
with time of use, even more if associated to ster-
oids. When there is the need for invasive procedure, 
such as oral surgeries, and patient is under some oral 
bisphosphonate for osteoporosis, the recommendation 
is to withdraw the drug three months before and three 
months after the procedure. This approach is based on 
studies reporting oscillations of osteoclasts function dur-
ing the period of drug administration, which improve in 
cases of osteonecrosis22. Also to prevent osteonecrosis 
during the use of bisphosphonates, it is recommended 
that patients avoid smoking and alcohol23.
According to recent coagulation studies which describe 
ischemic alveolar bone marrow changes as cause of 
cavitation after tooth extraction, it is proposed that jaw-
bone osteonecrosis could be result of thrombosis with or 
without hypofibrinolysis, which would obstruct vascular 
spaces, impairing blood flow to the region. In this situa-
tion, intramedullary pressure would be decreased produ-
cing hypoxia and cell death13,14,24. Toxins, immunoglobu-
lins and inflammatory mediators released in necrotic or 
ischemic regions would stimulate nervous terminations 
which would produce neurogenic pain9.
INCIDENCE
NICO incidence by gender is of four females for one 
male. This number takes into account medical records 
and research of such entity in groups of patients. Female 
predominance may reach 80% and is explained by two 
reasons: more personal care of females as compared to 
males and because they look for help more often due 
to the use of hormones as replacement therapy or the 
use of contraceptives. The use of female hormones by 
females with hereditary hypercoagulation disorders in-
creases the risk for venous thrombosis and tissue infarc-
tion. With regard to age, females above 65 years of age 
have a higher risk for developing NICO than the remain-
ing population, however the highest incidence is seen in 
middle-aged people between 35 and 55 years of age1,2. 
NATURE OF PAIN
NICO pain is still not totally explained and falls into 
the infectious theory which is still controversial be-
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cause it may mask its real cause. Another explana-
tion suggests that pain may be caused by bone fluid 
exchanges resulting from ischemia and from inflam-
mation mediators, more than nervous lesions. Vessels 
and nerves may be affected by increased pressure and 
ischemic thrombosis allowing the development of 
nervous injury1,13.
Major symptom of this disease is a severe pain in 
the face or in the alveolar bone3,4,25, in trigeminal 
nerve distribution sites, being piercing, paroxysmal 
and may be continuous in some cases. More affected 
regions are tooth extraction sites both in the man-
dible and jawbone, and may also be bilateral7,8. In 
general, it is not possible to see mucosal changes 
or some other type of oral manifestation at clinical 
evaluation. In a study8 with 2023 patients, 48% re-
ported pain in the region of the third lower molars, 
which has been described as in shock and paroxysmal, 
being it totally or partially controlled with anesthetic 
block of the affected region. Some patients also pre-
sented diplopia, nasal congestion, balance changes 
and face dysesthesia, in addition to pain4.
DIAGNOSIS
To adequately diagnose NICO, it is necessary, in addi-
tion to clinical information, to use additional exams. 
Studies3,19 have proposed the following diagnostic cri-
teria: pain in the alveolar bone in regions innervated 
by the trigeminal nerve and temporary pain relief when 
the region is submitted to anesthetic block.
NICO also interferes with quality of life and may be 
easily mistaken for other neuropathic and / or deep 
somatic musculoskeletal and visceral diseases4,8,9,25-29.
IMAGING EXAMS
Conventional exams, such as periapical and panoramic 
X-rays, sometimes are not enough for an accurate NICO 
diagnosis.
Chronic bone diseases caused by lack of blood flow 
are difficult to see in imaging exams leading to a high 
false-negative rate. In alveolar bone marrow disease, up 
to half the cancellous bone may be destroyed without 
significant radiographic changes which would only be 
detected by an experienced eye and a thorough X-rays 
analysis1,11,12. Studies1,2 have published NICO radio-
graphic findings reporting the presence of light and 
discrete radiolucent areas, like soap bubbles, and the 
presence of radiopaque areas in the shape of cotton. It 
is possible to radiographically observe the lack of nor-
mal bone tissue healing, with the presence of lamina 
dura close to the alveolus, in the regions corresponding 
to the zones were teeth had been extracted.
These same authors also reported1,2 that ischemic 
osteonecrosis is difficult to see in conventional X-
rays, however when present it appears as a radiolucent 
area and there may be a weak oval central sclerosis 
surrounded by a thick radiolucent circle which is also 
surrounded by a thick sclerotic ring however poorly 
distinct, being also described as “bull’s eye lesion”.
Bone scintigraphy using technetium 99 is the golden 
standard for bone marrow ischemia diagnosis. This 
technique is still being used although being expensive 
and needing intravenous contrast injection, in addi-
tion to resulting in 30% of false-negatives1,11,12.
HISTOLOGICAL EXAM
The histopathology of ischemic osteonecrosis is 
directly related to its duration and to the intensity 
of blood flow decrease in the medullary bone. Char-
acteristics of bone marrow edema include dilated 
and sinusoidal medullary capillaries, serous exudate 
around blood vessels, presence of adipocytes, deli-
cate fiber bundles (ischemic myelofibrosis) between 
fat cells, areas of dense fibrosis and a slight disper-
sion of chronic inflammatory cells in myelofibrosis 
regions. Trabecular bones in general remain viable, 
however inactive, thin and largely spaced. It is pos-
sible to find focal areas of medullary hemorrhage or 
microinfarctions, considered by some as pathognom-
onic signals of osteonecrosis.
When there is necrotic bone tissue, there is also the 
lack of osteocytes foci. One may also find stained 
globular calcified necrotic debris masses which 
may also be darkened. The heat generated by rotary 
tools may also generate necrotic debris similar to 
those caused by ischemia, however these are more 
peripheral in tissue fragments, which allows for their 
differentiation1,2,9.
TREATMENT
Treatment is based on clinical and imaging exams. 
Surgery is performed with complete resection of the 
bone tissue corresponding to the painful zone, using 
bone marrow curettage and placing in the site a sponge 
impregnated with antibiotics1-4. It is also possible to 
use local infiltration with tetracycline alone or com-
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bined with cephalexin with 90% improvement which 
may last from two months to nine years3.
Other authors30 have studied the effects of warfarin, an 
anticoagulant, in 10 patients with NICO and thrombo-
philia and the use of stanozolol, an anabolic steroid, 
in 20 patients with osteopathy and hypofibrinolysis. 
Results have shown that both warfarin and stanozolol 
may be used to treat osteopathies, NICO and hypofib-
rinolysis, however these drugs have relieved pain in 
just 5% of cases.
DISCUSSION 
Current dentistry is improving a lot the 
biocompatibility of materials used in procedures, how-
ever, several still cause bone tissue lesions31. Materials 
such as heavy metals, lead and phosphorus, products 
used for disinfections of root canals for endodontic 
treatments, use of anesthetics with vasoconstrictor and 
local application of steroids, associated to old age and 
hereditary factors related to thrombophilia and hypo-
fibrinolysis13,141,18,22 are major NICO causes, in addition 
to surgery-related infections1-4. This disease has a silent 
onset causing pain and discomfort only at an advanced 
stage of bone commitment3,4,. Added to these factors, 
NICO is also difficult to diagnose because most of the 
times it is not diagnosed with conventional X-rays1,11,12, 
needing more accurate exams such as scintigraphy11. 
NICO must be differentiated from trigeminal, glosso-
pharyngeal and superior laryngeal nerve neuralgias, 
from atypical toothache, Eagle’s syndrome, Ernest’s 
syndrome and temporomandibular dysfunction. Table 
1 describes differences and similarities between NICO 
and other bucofacial pains25-63.
Trigeminjal neuralgia is the most frequent facial 
neuralgia, presenting as a piercing pain in electric 
shock, limited to regions innervated by the fifth cra-
nial nerve. It normally affects individuals between 
50 and 70 years of age, with mean age of 50 years 
and mostly females. Pain attack is sudden, triggered 
by a tactile stimulation in points known as triggering 
points. Pain may last from seconds to minutes, may 
occur many times a day without motor changes in the 
affected area. Neuromodulators significantly improve 
pain in the beginning, and there may be pain latency 
periods. There are cases where pain returns without 
apparent reasons25-29,32-35.
Glossopharyngeal neuralgia is similar to trigeminal 
neuralgia being differentiated by the anatomic site. It 
occurs between 15 and 85 years of age, with mean age 
of 50 years. It is an episodic, unilateral pain like an 
electric shock, piercing and severe. Attacks are short, 
from 30 to 60 seconds, and may be repeated for some 
hours. Pain trigger seems to be swallowing, yawn-
ing, speech, chewing or touching the tonsil with some 
tool. In general, the site of more severe pain referred 
by patients is below the mandible angle and triggering 
points may be located close to the external acoustic 
meatus27,32,36,37. 
Superior laryngeal nerve neuralgia manifests as acute, 
unilateral, short duration, electric shock pain located 
in the lateral pharyngeal area, submandibular area 
and infra-auricular or auricular area. There is no pre-
dilection for gender or age. It may be triggered by 
swallowing, shouts, head rotation and blowing the 
nose. Triggering zones of this disease are located in 
the hypothyroid region and in the lateral pharyngeal 
region. Laboratory and imaging exams do not show 
changes, thus poorly contributing for the diagnosis. 
Clinical pain characteristics, its duration and na-
ture, associated to anesthetic blocks and the use of 
neuromodulators help diagnosis and treatment32,38-41. 
Atypical toothache is a persistent pain in the maxillo-
facial region which does not follow the diagnostic cri-
teria for any other orofacial pain and does not have an 
identifiable cause. It affects especially females, with 
mean age of 40 years, but may also occur during ado-
lescence. Pain may be located in a small area of the 
face or extend to associated areas, such as temporal 
and cervical regions27,28,32. Pain is described as deep, 
diffuse, continuous and persistent and may present 
sensation of burning or pressure. Pain may be started 
by an invasive dental treatment or surgery42-44.
Eagle’s syndrome is a disease affecting styloid pro-
cesses, which are extensions of the temporal bone 
with length varying from 15 to 30 millimeters. Such 
bone gives origin to stylopharyngeal, styloglossus and 
stylo-hioid muscles. The disease is manifested due to 
the elongation of the styloid process generating electric 
shock pain or stabbing pain in the cervical pharyngeal 
region irradiating to the mastoid region and worsened 
during swallowing. It affects more females between 
30 to 50 years of age. Patients report sensation of for-
eign body in the throat with pain at head rotation, in 
the shoulders and headache. Tonsillar fossa palpapa-
tion worsens pain. The diagnosis may be confirmed by 
anesthetic infiltration of the tonsillar fossa which tem-
porarily relieves pain while the effects of the anesthetic 
persist, and by X-rays showing the styloid process with 
more than 30 mm length45-53.
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Ernest’s syndrome is caused by the inflammation 
of the stylomandibular ligament. This condition is 
caused by trauma in the mandibular region, skull or 
face. Mandibular osteotomies where distraction and 
mobility are promoted may also be causes. Diagnosis 
is based on clinical history, clinical evaluation with 
palpation of the stylomandibular ligament insertion 
by extraoral access, and anesthetic block may be used 
in the insertion of such ligament which will confirm 
such syndrome because pain disappears and returns 
after anesthetic recovery. Diagnosis is then clinical 
since radiographically such disease is not detected. It 
is an inflammation without ligament calcification54,55.
Temporomandibular dysfunction is a set of conditions 
associated to stomathognatic system abnormalities 
which trigger not only joint dysfunction but also of ad-
jacent tissues, including facial and cervical muscles. 
It affects individuals of different ages, from 20 to 80 
years of age, especially females. Clinical characteris-
tics and most common symptoms are electric shock 
localized pain and / or in pressure in the TMJ with 
the function, articular noise(s) during mouth opening 
and closing, or both, deviation or mandibular deflec-
tion and mouth opening limitation. It may also present 
as continuous, constant and diffuse facial pain which 
worsens with mandibular movement and /or palpa-
tion of masticatory and cervical muscles, earache, 
headache and cervical pain. All these characteristics 
may be associated to parafunctional habits deleteri-
ous for joint and dental tissues, such as bruxism, nail 
biting and history of trauma or mandibular fracture61. 
Imaging exams may help the diagnosis. Transcranial 
and cephalometric X-rays and CTs are commonly 
used, however the golden standard for the diagnosis 
of intra-articular diseases is MRI27,32,56-58.
CONCLUSION
NICO is caused by trauma, dental surgical 
procedures, by the direct action of drugs daily used 
Table 1. Differences and similarities between NICO and other bucofacial pains
NICO Trigeminal neuralgia
Glossopharyngeal 
neuralgia
Superior 
laryngeal nerve 
neuralgia 
Atypical  
toothache
Eagle’s  
syndrome TMD
Ernest’s 
syndrome
Pain  
location
Region in-
nervated by 
the trigeminal 
nerve.
Areas inner-
vated by the 
trigeminal 
nerve.
Áreas innervated by 
the glossopharyngeal 
nerve.
Lateral region 
of pharynx, 
submandibular, 
infra-auricular 
and auricular 
regions
Close to the 
region of upper 
molars and 
premolars 
Cervical region, 
pharynx and 
mastoid
Pre-auricular, 
masseter, 
occipital and 
temporal 
regions
Lower auricular,  
temporal and 
posterior  
teeth regions
Age  40-50 years  50-70 years 15-85 years --  40 years and also adolescence 30-50 years  20-80 years Varied
Gender F>M F>M       - M=F F>M F>M F>M     -
Quality of 
pain
Electric shock, 
pulsatile and 
piercing.
Electric 
shock or 
burning
Electric shock or 
burning Electric shock
Constant, diffuse 
and in pressure
Electric shock and 
/ or stabbing
Electric shock, 
pressure,  
pulsatile, 
continuous, 
Constant, 
or all
Pulsatile
Duration 1 to 2 seconds /constant
Few seconds 
to minutes
30 to 60 seconds and 
may repeat for some 
hours
May last for 
minutes 
From short 
episodes to 
constant.
According to 
stimulation.
According to 
severity 
According to 
severity
Frequency 
of pain
1 day to 
constant
Several 
times a day Several times a day
Several times 
a day Varied
Varies according 
to stimulation Varied Varied
Stimulation No Slight touch on the face, 
Yawning, swal-
lowing
/swallowing, 
shouts, head 
rotation
Varied
Swallowing, ton-
sil palpation and 
head rotation.
Stomato-
gnathic system 
functions 
Palpation of  
stylomandibular  
ligament and  
mandibular 
protrusion
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by dentists, by pathogenic agents acting on the bone 
tissue, and by genetic character, especially related to 
blood coagulation problems such as thrombophilia 
and hypofibrinolysis. The search for new drugs less 
detrimental for bone tissues and more information 
to dentists about NICO may help decreasing its inci-
dence by establishing an earlier diagnosis, thus mak-
ing different management techniques more effective.
REFERÊNCIAS
1. Bouquot JE, Roberts AM, Person P, et al. 
Neuralgia-inducing cavitational osteonecrosis 
(NICO): Osteomielitis in 224 jawbone samples from 
patients with facial neuralgia. Oral Surg Oral Med 
Oral Pathol 1992;73(3):307-19.
2. Bouquot JE, Christian J. Long-term effects of jaw-
bone curettage on the pain of facial neuralgia. J Oral 
Maxillofac Surg 1995;53(4):387-99.
3. Ratner EJ, Person P, Kleinman DJ, et al. Jawbone 
cavities and trigeminal and atypical facial neuralgias. 
Oral Surg Oral Med Oral Pathol 1979;48(1):3-20.
4. Ratner EJ, Langer B, Evins ML. Alveolar cavita-
tional osteopathosis. Manifestations of an infectious 
process and its implication in the causation of chronic 
pain. J Periodontol 1986;57(10):593-603.
5.Sardella A, Demarosi F, Barbieri C, et al. An up-to-
date view on persistent idiopathic facial pain. Min-
erva Stomatol 2009;58(6):289-99. 
6. Woda A, Pionchon PA. Unified concept of 
idiopathic orofacial pain: pathophysiologic features. J 
Orofac Pain 2000;14(3):196-212
7. Roberts AM, Person P, Chandran NB, et al. Further 
observations on dental parameters of trigeminal an 
atypical facial neuralgias. Oral Surg Oral Med Oral 
Pathol 1984;58(2):121-9.
8. Bouquot JE, McMahon RE. Ischemic alveolar 
osteonecrosis in 2.023 patients with chronic facial 
pain. J Orofacial Pain 1997;11(2):180-6 
9. Adams WR, Spolnik KJ, Bouquot JE. Maxillofacial 
osteonecrosis in a patient with muItiple “idiopathic” 
facial pains. J Oral Pathol Med 1999;28(9):423-32.
10. Zuniga JR. Challenging the neuralgia-inducing 
cavitional osteonecrosis concept. J Oral Maxillofac 
Surg 2000;58(9):1021-8.
11. DeNucci DJ Chen CC, Sobiski C, et al. The 
use of SPECT bone scans to evaluate patients with 
idiopathic jaw pain SPECT Oral Surg Oral Med Oral 
Pathol Oral Radiol Endod 2000;90(6):750-7. 
12. Feinberg LS, Stephan RB, Fogarty KP, et al. Reso-
lution of cavitational osteonecrosis through neuromo-
dulation technique, a novel form of intention-based 
therapy: a clinical case study. J Altern Complement 
Med 2009;15(1):25-33.
13. Glueck CJ, McMahon RE, Bouquot J, et al. Throm-
bophilia, hypofibrinolysis, and alveolar osteonecrosis 
of the jaws. Oral Surg Oral Med Oral Pathol Oral Ra-
diol Endod 1996;81(5):557-66.
14. Gruppo R, Glueck CJ, McMahon RE, et al. The 
pathophysiology of alveolar osteonecrosis of the 
jaws: anticardiolipin antibodies, trombophilia, and 
hypofibrinolysis. J Lab Clin Med 1996;127(5):481-8.
15. Glueck CJ, Freiberg R, Glueck HI, et al. Idio-
pathic osteonecrosis, hypofibrinolysis, high activator 
inhibitor, high lipoprotein (a), and therapy with stano-
zonol. Am J Hemathol 1995;48(4);213-20.
16. Glueck CJ, McMahon RE, Bouquot JE, et al. 
Heterozygosity for the Leiden mutation of the factor 
V gene, a common pathoetiology for osteonecrosis of 
the jaw, with thrombophilia augmented by exogenous 
estrogens. J Lab Clin Med 2007;130(5):540-3. 
17. Glueck CJ, Freiberg RA, Boppana S, et al. Throm-
bophilia, hypofibrinolysis, the eNOS T-786C poly-
morphism, and multifocal osteonecrosis J Bone Joint 
Surg Am 2008;90(10):2220-9.
18. Glueck CJ, Glueck HI, Mieczkowski L, et al. 
Familial high plasminogen activator inhibitor with 
hypofibrinolysis: a new pathophysiologic cause of 
osteonecrosis? Thromb Haemost 1993;69(5):460-5.
19. Bouquot JE, McMahon RE. Neuropathic pain in 
maxillofacial osteonecrosis J Oral Maxillofac Surg 
2000;58(9):1003-20.
20. Gegler A, Cherubini K, Figueiredo MAS, et al. 
Bisfosfonatos e osteonecrose maxilar: revisão da 
literatura e relato de dois casos. Rev Bras Cancerol 
2006;52(1):25-31.
21. Agarwaal S, Sule A, Pai BU, et al. Alendronate in 
the treatment of vascular necrosis of the hip. Rheuma-
tology 2002;41(3):346-7.
22. Ruggiero SL, Dodson TB, Assael LA, et al. 
American Association of Oral and Maxillofacial 
Surgeons position paper on bisphosphonate-related 
osteonecrosis of the jaw - 2009 update. Aust Endod J 
2009;35(3):119-30.
23. Khan AA, Sándor GK, Dore E, et al. Canadian 
consensus practice guidelines for bisphosphonate 
associated osteonecrosis of the jaw. J Rheumatol 
2008;35(7):1391-7.
24. Glueck CJ, McMahon RE, Bouquot JE, et al. 
Exogenous estrogens may exacerbate thrombo-
Neuralgia Inducing cavotational.indd   162 6/21/12   2:32 PM
Neuralgia inducing cavitational osteonecrosis Rev Dor. São Paulo, 2012 jan-mar;13(1):000-0
163
philia, impair bone healing and contribute to de-
velopment of chronic facial pain. J Craniomand 
Pract 1998;16(3):143-53.
25. Roberts AM, Person P. Etiology and treatment of 
idiopathic trigeminal and atypical facial neuralgia. 
Oral Surg Oral Med Oral Pathol 1979;48(4):298-308.
26. Benoliel R, Eliav E. Neuropathic oro-
facial pain. Oral Maxillofac Surg Clin North Am 
2008;20(2):237-54.
27. Okeson JP, de Leeuw R. Differential diag-
nosis of temporomandibular disorders and other 
orofacial pain disorders. Dent Clin North Am 
2011;55(1):105-20.
28. Linn J, Trantor I,Teo N, et. The differential diag-
nosis of toothache from other orofacial pains in clin-
ical practice. Austral Dental J 2007;52:(1):100-4.
29. Devor M, Amir R, Rappaport ZH. Pathophysiol-
ogy of trigeminal neuralgia: the ignition hypothesis. 
Clin J Pain 2002;18(1):4-13.
30. Glueck CJ, McMahon RE, Bouquot JE, et al. A 
preliminary pilot study of treatment of thrombophilia 
and hypofibrinolysis and amelioration of the pain of 
osteonecrosis of the jaws. Oral Surg Oral Med Oral 
Pathol Oral Radiol Endod 1998;85(1):64-73.
31. Shankland WE 2nd. Medullary and odonto-
genic disease in the painful jaw: Clinicopatho-
logic review of 500 consecutive lesions. Cranio 
2002;20(4):295-303.
32. Teixeira MJ, Siqueira SRDT. Neuralgias do seg-
mento facial. JBA 2003;3(10):101-10. 
33. Larsen A, Piepgras D, Chyatte D, et al. Trigeminal 
neuralgia: diagnosis and medical and surgical man-
agement. JAAPA 2011;24(7):20-5. 
34. Viana M, Glastonbury CM, Sprenger T, et al. Tri-
geminal neuropathic pain in a patient with progres-
sive facial hemiatrophy (parry-romberg syndrome). 
Arch Neurol 2011;68(7):938-43.
35. Karibe H, Goddard G, McNeill C, et al. Compari-
son of patients with orofacial pain of different diag-
nostic categories. Cranio 2011;29(2):138-43. 
36. Isbir CA. Treatment of a patient with glosso-
pharyngeal neuralgia by the anterior tonsillar pillar 
method. Case Rep Neurol 2011;21(3):27-31.
37. Martínez-González JM, Martínez-Rodríguez N, 
Calvo-Guirado JL, et al. Glossopharyngeal neuralgia: 
a presentation of 14 cases. J Oral Maxillofac Surg 
2011;69(6):38-41.
38. Bruyn GW. Superior laryngeal neuralgia. 
Cephalalgia 1983;3(4):235-40. 
39. Kodama S, Oribe K, Suzuki M. Superior laryngeal 
neuralgia associated with deviation of the hyoid bone. 
Auris Nasus Larynx 2008;35(3):429-31. 
40. Aydin O, Ozturk M, Anik Y. Superior laryngeal 
neuralgia after acute laryngitis and treatment with a 
single injection of a local anesthetic. Arch Otolaryn-
gol Head Neck Surg 2007;133(9):934-5. 
41. Takahashi Sato K, Suzuki M, Izuha A, et al. Two 
cases of idiopathic superior laryngeal neuralgia treated 
by superior laryngeal nerve block with a high concen-
tration of lidocaine. J Clin Anesth 2007;19(3):237-8.
42. Grossmann E, Fabiano RP, Girard L. Odontalgia 
atípica: relato de caso. Alcance (UNIVALI), Santa 
Catarina 1997;3:65-7.
43. Zagury JG, Eliav E, Heir GM, et al. Prolonged 
gingival cold allodynia: a novel finding in patients 
with atypical odontalgia. Oral Surg Oral Med Oral 
Pathol Oral Radiol Endod 2011;111(3):312-9. 
44. Wirz S, Ellerkmann RK, Buecheler M, et al. 
Management of chronic orofacial pain: a survey of 
general dentists in German university hospitals. Pain 
Med 2010;11(3):416-24. 
45. Higino, TCM, Tiago RSL, Belentani FM, et al. 
Síndrome de Eagle: relato de três casos. Arq Int Otor-
rinolaringol 2008;12(1):141-4.
46. Grossmann E, Paiano G. Eagle’s syndrome: a case 
report. Cranio 1998;16(2):126-30.
47. Grossmann E, Collares MVM, Martelete M, et 
al. Eagle´s syndrome associated with an accidental 
fracture of the styloid process: a case report. Braz J 
Craniomaxillof Surg 1999;2(1):25-7.
48. Jain D, Chauhan JS, Jain S, et al. Elongated styloid 
process: an unusual cause of neck pain and difficulty 
in swallowing. J Orofac Pain 2011;25(3):269-71. 
49. Peng GG, Chen WL, Wu JW, et al. Eagle’s syn-
drome treated with dissection of the styloid process 
via an extraoral approach combined with antidepres-
sants. Chin J Dent Res 2011;14(1):37-40. 
50. Tekaya R, Neji O, Naccache I, et al. Eagle’s 
syndrome: a rare cause of neck pain. Tunis Med 
2011;89(5):503-4. 
51. Colby CC, Del Gaudio JM. Stylohyoid complex 
syndrome: a new diagnostic classification. Arch Oto-
laryngol Head Neck Surg 2011;137(3):248-52. 
52. Williams JV, McKearney RM, Revington PJ. 
Eagle’s syndrome: a novel surgical approach to the 
styloid process using a preauricular incision. J Oral 
Maxillofac Surg 2011;69(6):1617-22. 
53. Yavuz H, Caylakli F, Erkan AN, et al. Modi-
fied intraoral approach for removal of an elongat-
ed styloid process. J Otolaryngol Head Neck Surg 
Neuralgia Inducing cavotational.indd   163 6/21/12   2:32 PM
Grossmann, Cousen, Grossmann et al.Rev Dor. São Paulo, 2012 jan-mar;13(1):000-0
164
2011;40(1):86-90. 
54. Shankland WE 2nd. Ernest syndrome as a conse-
quence of stylomandibular ligament injury: a report 
of 68 patients. J Prosthet Dent 1987;57(4):501-6.
55. Lima Júnior JL, Araujo TN, Honfi Júnior ES, et 
al. Síndrome de Ernest: Revisão de Literatura. Re-
vista Odonto Ciências – Faculdade de Odontologia 
PUCRS. 2007;22(57):275-9.
56. Pereira KNF, de Andrade LLS, da Costa MLG, 
et al. Sinais e sintomas de pacientes com disfun-
ção temporomandibular. Rev CEFAC, São Paulo 
2005;7(2):221-8.
57. Grossmann E. Dor facial: diagnóstico e trata-
mento. Âmbito Hospitalar 2009;1(194): 67-75.
58. Grossmann E. Exame do paciente com dis-
função temporomandibular. Âmbito Hospitalar 
2011;207(1):37-43.
Submitted in September 12, 2011.
Accepted for publication in January 05, 2012.
Neuralgia Inducing cavotational.indd   164 6/21/12   2:32 PM
